About Ciclofilin Pharmaceuticals
Ciclofilin Pharmaceuticals is a company based in San Diego (United States) founded in 2014 was acquired by Hepion Pharmaceuticals in May 2016.. Ciclofilin Pharmaceuticals has raised $50 thousand across 1 funding round from investors including Hepion Pharmaceuticals. Ciclofilin Pharmaceuticals operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ciclofilin Pharmaceuticals Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$50 K (USD)
in 1 rounds
-
Latest Funding Round
$50 K (USD), Seed
Jun 27, 2014
- Investors
-
Employee Count
Employee Count
-
Acquired by
Hepion Pharmaceuticals
(May 31, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ciclofilin Pharmaceuticals
Ciclofilin Pharmaceuticals has successfully raised a total of $50K through 1 strategic funding round. The most recent funding activity was a Seed round of $50 thousand completed in June 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $50,000
-
First Round
First Round
(27 Jun 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2014 | Amount | Seed - Ciclofilin Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ciclofilin Pharmaceuticals
Ciclofilin Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Hepion Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides therapeutics for chronic liver disorder
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ciclofilin Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ciclofilin Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ciclofilin Pharmaceuticals Comparisons
Competitors of Ciclofilin Pharmaceuticals
Ciclofilin Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| domain | founded_year | HQ Location |
Developer of biologics to treat hepatitis B infection
|
|
| domain | founded_year | HQ Location |
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ciclofilin Pharmaceuticals
When was Ciclofilin Pharmaceuticals founded?
Ciclofilin Pharmaceuticals was founded in 2014.
Where is Ciclofilin Pharmaceuticals located?
Ciclofilin Pharmaceuticals is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Ciclofilin Pharmaceuticals a funded company?
Ciclofilin Pharmaceuticals is a funded company, having raised a total of $50K across 1 funding round to date. The company's 1st funding round was a Seed of $50K, raised on Jun 27, 2014.
What does Ciclofilin Pharmaceuticals do?
Ciclofilin Pharmaceuticals was founded in 2014 in San Diego, United States, as a preclinical-stage biotech firm. Focus is placed on cyclophilin inhibitors targeting infectious, inflammatory, and degenerative diseases, particularly chronic hepatitis. The lead candidate, CPI-431-32, undergoes preclinical trials for HBV and HCV, blocking viral entry, replication, and liver fibrosis while enhancing natural defenses. Acquisition by ContraVir occurred in May 2016 for 17 million.
Who are the top competitors of Ciclofilin Pharmaceuticals?
Ciclofilin Pharmaceuticals's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
Who are Ciclofilin Pharmaceuticals's investors?
Ciclofilin Pharmaceuticals has 1 investor. Key investors include Hepion Pharmaceuticals.